STAT
We’re inching closer to a new vaccine for Lyme disease. But will the public accept it?
As the threat of Lyme disease grows and fears surrounding it spread faster than the ticks that carry the infection, ...
We’ve almost eradicated Polio. But recent measles outbreaks show us why the battle isn’t over.
[T]he polio campaign must push on across the finish line. Failure to do so could have dire consequences. ... For ...
Making a new generation of beauty products from viruses and bacteria
As scientists uncover more details about the skin microbiome, small startups and beauty giants alike are exploring how the trillions ...
Viewpoint: Here’s why we should cut back on cancer screening for the elderly
Although some of my patients are still working full time or traveling the world in their 70s and 80s, I ...
Viewpoint: I wish I learned about my breast cancer risk from a genetic counselor instead of 23andMe
I opened the email from 23andMe, saying a report was ready for me to read. That click changed my life ...
Rushing to revamp international gene-editing rules before ‘crazy people’ start opening embryo-editing clinics
The second-most shocking thing He Jiankui told the international genome editing summit in Hong Kong last November — right after ...
FDA mulling whether patients should have to pay to join clinical trials
Some [clinical trials] plan to ask participants to pay $7,000 or so to enroll. Another wanted to ask for upward ...
Viewpoint: ‘Natural’ is a feel-good label that can deceive us about the safety of medicine, beauty products and food
People believe that a host of items including foods, medicines, beauty products, cigarettes, lighting, and even causes of injuries are ...
Seeking origins of schizophrenia, autism by putting ‘stress’ on mini-placenta, mini-brains
Biologist Jennifer Erwin of the Lieber Institute for Brain Development, however, has no intention of babying her organoids: the world’s ...
Viewpoint: We need to stop worrying about whether people can cope with bad news from genetic tests
When the Human Genome Project began in 1990, bioethicists feared that giving people the results of genetic tests would do ...
There’s a medical dispute over how long it takes to predict recovery prospects for patients with traumatic brain injuries
The current practice in most ICUs is to help families make a decision about whether to withdraw life support within ...
‘Google’ for biomedical data could improve our understanding of diseases, improve treatments
If we aggregated all the data from countless years of research, might we learn something new about ourselves, the diseases ...
Mayo Clinic versus Natural News: Rating the reliability of health websites
For millions of Americans, including health professionals, the resurgence of measles is a confounding and frightening development. How can a ...
Convulsive seizures could play a key role in Alzheimer’s disease
It’s no surprise to neurologists that some people experience convulsive seizures in the later stages of [Alzheimer’s] disease. … But ...
Frequent errors with popular dementia test prompt review, new training requirements
Dr. Ronny Jackson, then the White House physician, gave Donald Trump a standard test to detect early signs of dementia ...
Heart monitoring by Fitbit, other wearables, may be less accurate for people with dark skin
Nearly all of the largest manufacturers of wearable heart rate trackers rely on technology that could be less reliable for ...
First attempt at using CRISPR to edit genes inside the body targets inherited form of blindness
Patients are about to be enrolled in the first study to test a gene-editing technique known as CRISPR inside the ...
Genetic sequencing of 50-year-old tissue sample boosts theory that HIV emerged 100 years ago
For more than 50 years, the RNA remained hidden in a lymph node that had been snipped out of a ...
LGBT people may have higher risk for Alzheimer’s, dementia. Are social stressors to blame?
LGBT Americans report increased rates of memory loss and confusion — two early signs of dementia — compared to their ...
Viewpoint: Trump’s proposed drug price cap would threaten gene therapies, cell-based therapies by stifling innovation
President Trump has said he plans to issue an executive order to lower what the United States government would pay ...
‘Cancer vaccine’ boosts survival rates when combined with immunotherapy drugs in small study
The largest study to date of a “cancer vaccine” plus one of the immunotherapy drugs that has revolutionized cancer treatment ...
We may soon have a routine blood test for Alzheimer’s risk
Scientists are closing in on a long-sought goal — a blood test to screen people for possible signs of Alzheimer’s ...
Spinal cord tumor illustrates long-term risks of controversial stem cell therapies
Stem cell therapies have the potential to treat many conditions, but so far there’s little proof that they do. Even ...
Creating a synthetic version of the Ebola virus to help fight the real thing
Scientists at the Centers from Disease Control and Prevention have created a synthetic version of the Ebola virus circulating in ...
Deadly superbug Candida auris is wreaking havoc in hospitals. Where’s the research money needed to stop it?
In the universe of scary drug-resistant pathogens that can kill, Candida auris is having a moment. The freaky fungus, which ...
How a combination of rare mutations created devastating heart problems for this family
Heritable diseases — say Huntington’s, sickle cell anemia, or cystic fibrosis — are typically thought of as the result of ...
AI promises to improve cancer care through precision medicine. Oncologists are starting to agree.
To get a better handle on the collective “take” on artificial intelligence for cancer care, my colleagues and I at ...
